codeine methylbromide

Codeine methylbromide is a small molecule opioid analgesic and antitussive, classified as the bromomethane (methylbromide) salt of codeine. Unlike other common codeine salts (such as phosphate or hydrochloride), it is considered a distinct drug due to its dual mechanism of action, combining the effects of both codeine and bromides. It was first synthesized in Austria-Hungary in 1903. The compound has been used for pain associated with insomnia or nervousness and for violent coughing, leveraging both the opioid properties of codeine (analgesia, cough suppression) and the sedative/calming effects typical of bromides. Codeine methylbromide is a Schedule I controlled substance in the United States, indicating no currently accepted medical use and high potential for abuse[1][2][4].

Brand names

Eucodineucodeine

Other names

Codeine bromomethylatemethobromide125-27-9